Urologix, Inc.

Urologix, Inc. develops, manufactures, and markets minimally invasive medical products for the treatment of urological disorders in the United States and internationally. It provides non-surgical, catheter-based therapies that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia, a non-cancerous disease. The company offers control units under the Targis, Prostatron, and CoolWave names; and procedure kits under CTC, Targis, and Prostaprobe names. Urologix also involves in developing generation catheter under CoolMax name with a focus on combining durability with patient comfort. It sells its products to hospitals and urologists through local distributors and independent agents. The company was founded in 1991 and is based in Minneapolis, Minnesota.